Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)

Jonasova, A., Neuwirtová, R., Polackova, H., Šišková, M., Stopka, T., Cmunt, E., Belickova, M., Moudrá, A., Minařík, L., Fuchs, O., Michalová, K., Zemanová, Z. Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients). Leukemia Research. 2018, 69(June), 12-17. ISSN 0145-2126. E-ISSN 1873-5835. Dostupné z: doi: 10.1016/j.leukres.2018.03.015.